secwatch.observer — SEC 8-K summary
======================================

Issuer:     Repare Therapeutics Inc. (—)
CIK:        0001808158
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001193125-25-033718
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Repare Therapeutics cuts workforce ~75%, expects $21M annual savings; CMO departs
--------------------------------------------------------------------------------

- Board approved ~75% workforce reduction on Feb 23, 2025; affected employees notified Feb 24.
- One-time cash charges: ~$7.3M severance + up to $1.4M retention costs, through Q4 2025.
- Annual operating expense savings of ~$21M expected from the reorganization.
- CMO Maria Koehler to depart March 31, 2025; severance includes nine months salary, $150k payment, COBRA, equity acceleration.
- CFO Steve Forte gets $175k retention bonus; CSO Mike Zinda receives $150k retention bonus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808158/000119312525033718/0001193125-25-033718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808158/000119312525033718/d859090d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-033718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer